Literature DB >> 26700077

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.

E Wardelmann1, R L Haas2, J V M G Bovée3, Ph Terrier4, A Lazar5, C Messiou6, C LePechoux7, W Hartmann1, F Collin8, C Fisher9, G Mechtersheimer10, A P DeiTos11, S Stacchiotti12, R L Jones13, A Gronchi14, S Bonvalot15.   

Abstract

At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This manuscript, produced by a European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) endorsed task force, aims to propose standardization of the pathological examination process and the reporting of STS resection specimens after neoadjuvant radio- and/or chemotherapy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Guideline; Pathology; Radiotherapy; Response evaluation; Soft tissue sarcoma

Mesh：

Year:  2015        PMID： 26700077     DOI： 10.1016/j.ejca.2015.09.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


  18 in total

1.  Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.

Authors:  Emily Z Keung; Jen-Wei Tsai; Ali M Ali; Janice N Cormier; Andrew J Bishop; B Ashleigh Guadagnolo; Keila E Torres; Neeta Somaiah; Kelly K Hunt; Jennifer A Wargo; Alexander J Lazar; Wei-Lien Wang; Christina L Roland
Journal:  Oncoimmunology       Date:  2017-10-31       Impact factor: 8.110

2.  Sarcoma: Does histotype-tailored neoadjuvant therapy improve outcomes?

Authors:  Robin L Jones; Khin Thway
Journal:  Nat Rev Clin Oncol       Date:  2017-08-08       Impact factor: 66.675

3.  Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.

Authors:  Nicholas P Gannon; Matthew H Stemm; David M King; Meena Bedi
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-07       Impact factor: 4.553

4.  Can radiomics improve the prediction of metastatic relapse of myxoid/round cell liposarcomas?

Authors:  Amandine Crombé; François Le Loarer; Maxime Sitbon; Antoine Italiano; Eberhard Stoeckle; Xavier Buy; Michèle Kind
Journal:  Eur Radiol       Date:  2020-01-17       Impact factor: 5.315

Review 5.  Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?

Authors:  Amani Arthur; Edward W Johnston; Jessica M Winfield; Matthew D Blackledge; Robin L Jones; Paul H Huang; Christina Messiou
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

6.  High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.

Authors:  Amandine Crombé; François Le Loarer; François Cornelis; Eberhardt Stoeckle; Xavier Buy; Sophie Cousin; Antoine Italiano; Michèle Kind
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

7.  Treatment-related features improve machine learning prediction of prognosis in soft tissue sarcoma patients.

Authors:  Jan C Peeken; Tatyana Goldberg; Christoph Knie; Basil Komboz; Michael Bernhofer; Francesco Pasa; Kerstin A Kessel; Pouya D Tafti; Burkhard Rost; Fridtjof Nüsslin; Andreas E Braun; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2018-03-20       Impact factor: 3.621

8.  Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study.

Authors:  Marc G Stevenson; Lukas B Been; Harald J Hoekstra; Albert J H Suurmeijer; Ronald Boellaard; Adrienne H Brouwers
Journal:  EJNMMI Res       Date:  2018-06-07       Impact factor: 3.138

Review 9.  Neoadjuvant Treatment Options in Soft Tissue Sarcomas.

Authors:  Mateusz Jacek Spałek; Katarzyna Kozak; Anna Małgorzata Czarnecka; Ewa Bartnik; Aneta Borkowska; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2020-07-26       Impact factor: 6.639

10.  Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).

Authors:  Jens Jakob; Anna Simeonova; Bernd Kasper; Ulrich Ronellenfitsch; Geraldine Rauch; Frederik Wenz; Peter Hohenberger
Journal:  Radiat Oncol       Date:  2016-06-03       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.